aminocaproic acid has been researched along with Cancer of Skin in 3 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perides, G | 1 |
Zhuge, Y | 1 |
Lin, T | 1 |
Stins, MF | 1 |
Bronson, RT | 1 |
Wu, JK | 1 |
Guldbakke, KK | 1 |
Schanbacher, CF | 1 |
Shulkin, BL | 1 |
Argenta, LC | 1 |
Cho, KJ | 1 |
Castle, VP | 1 |
3 other studies available for aminocaproic acid and Cancer of Skin
Article | Year |
---|---|
The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis.
Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Ca | 2006 |
Disseminated intravascular coagulation unmasked by Mohs micrographic surgery.
Topics: Adenocarcinoma; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Carcinoma, Basal Cell | 2006 |
Kasabach-Merritt syndrome: treatment with epsilon-aminocaproic acid and assessment by indium 111 platelet scintigraphy.
Topics: Administration, Oral; Aminocaproic Acid; Angiography; Blood Platelets; Buttocks; Disseminated Intrav | 1990 |